MedTrace Logo

Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia Patients

NCT03119766 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2022-06-07

Study results available
· View outcomes & findings →

Summary

Purpose of the study:

To obtain additional data on efficacy and safety of Kolofort in the treatment of patients with functional dyspepsia.

Conditions

  • Dyspepsia

Interventions

DRUG

Kolofort

Oral administration

DRUG

Placebo

Oral administration

Sponsors & Collaborators

  • Materia Medica Holding

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2020-01-11
Completion
2020-01-11

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03119766 on ClinicalTrials.gov